A Delicate Balance: FDA and the Reform of the Medical Device Approval Process

ENTER MEMBER STATEMENTS HERE -- events/hr233hk.pdf" target="_blank Senator Herb Kohl (D-WI), Chairman END MEMBER STATEMENTS --
read more

ENTER MEMBER STATEMENTS HERE -- events/hr233hk.pdf" target="_blank Senator Herb Kohl (D-WI), Chairman END MEMBER STATEMENTS --

width="100%" size=2 align=center color="#0E005B Panel Statements

ENTER WITNESS STATEMENTS HERE --

events/hr233kk.pdf" target="_blankKatie Korgaokar, Patient, Denver, CO events/hr233mc.pdf" target="_blankMarcia Crosse, Health Care, Government Accountability Office, Washington, DC events/hr233dz.pdf" target="_blankDiana Zuckerman President, National Research Center for Women and Families, Cancer Prevention and Treatment Fund, Washington, DC events/hr233fr.pdf" target="_blankFrederic Resnic, Assistant Professor of Medicine, Harvard Medical School and Director of the Cardiac Catheterization Laboratory, Brigham and Women’s Hospital, Boston, MA events/hr233hr.pdf" target="_blankRalph Hall Distinguished Professor, University of Minnesota Law School, Minneapolis, MN events/hr233dn.pdf" target="_blankDavid Nexon, Senior Executive Vice President, Advanced Medical Technology Association (AdvaMed), Washington, DC events/hr233wm.pdf" target="_blankWilliam Maisel, Deputy Center Director for Science and the Chief Scientist, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, MD

END WITNESS STATEMENTS -- close

This program has not yet aired

Alert me when this program is:
More information about

A Delicate Balance: FDA and the Reform of the Medical Device Approval Process

0 Views
Program ID:
27587-1
Category:
Senate Committee
Format:
Senate Committee
Location:
Washington, District of Columbia, United States